pharma
Almost 400 Nigerian medical dispensaries shut down for sub-standard practice
October 28, 2019Manufacturing and Production, Medical Communications, Sales and Marketing Nigeria, pharma
Nigeria has seen almost 400 of its medicine dispensaries shut down over “unethical practices and lack of compliance, it has …
European approval announced for Astellas’ Xospata in FLT3+ treatment-resistant acute myeloid leukaemia
October 28, 2019Sales and Marketing Astellas, Xospata, leukaemia, pharma
Astellas has revealed that the European Commission has awarded marketing approval for Xospata (gilteritinib) as an oral, once-daily monotherapy for …
FlyPharma tackles supply chain challenges and industry best practice at another successful conference
October 24, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing flypharma, pharma
For its fifth annual Europe conference, FlyPharma chose Copenhagen as its host city to address the latest supply chain challenges …
Damage control: How will pharma manage the health economic impacts of Brexit?
October 23, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HEOR, brexit, health economics and outcomes research, pharma
When it comes to life sciences and patient outcomes, the UK’s destiny is inextricably tied to its relationship with the …
FDA approves Vertex’s Trikafta in new indication, now potentially covering 90% of cystic fibrosis patients
October 23, 2019Research and Development, Sales and Marketing FDA, Trikafta, Vertex, cystic fibrosis, pharma
The FDA has granted marketing authorisation to Vertex’s Trikafta (elexacaftor/tezacaftor/ivacaftor and ivacaftor) for the treatment of cystic fibrosis (CF), it …
BMS’ Opdivo+Yervoy+Chemo combo shows superior overall survival in first-line lung cancer
October 23, 2019Research and Development Bristol-Myers Squibb, Cancer, NSCLC, Yervoy, lung cancer, opdivo, pharma
Bristol Myers Squibb has lifted the curtain on new Phase 3 data for its blockbuster immunotherapy Opdivo (nivolumab), showing that …
Porton Biopharma signs potential $24m deal to push its intranasal anthrax vaccine into Phase 1 trials
October 22, 2019Manufacturing and Production, Research and Development FDA, Porton Biopharma, anthrax, pharma
Porton Biopharma has signed a modification to its existing agreement with the US National Institute of Health’s National Institute of …
Novo Nordisk opens first Pharmatech branch office in Singapore
October 22, 2019Manufacturing and Production Novo Nordisk, Singapore, pharma
Novo Nordisk has celebrated the launch of a new Pharmatech A/S branch office based in Singapore at a grand opening …
“No deal” Brexit and life sciences: What happens?
October 21, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EU, Europe, UK, brexit, no deal, no-deal, pharma
Prime Minister Boris Johnson may have agreed a withdrawal agreement with the European Union at the 11th hour, but despite …
FDA approves Alexion’s Ultomiris in atypical haemolytic uremic syndrome for adults and children
October 21, 2019Sales and Marketing Alexion, FDA, Ultomiris, pharma, rare disease
The FDA has moved to expand the existing label for Alexion’s Ultomiris (ravulizumab-cwvz) to include the treatment of atypical haemolytic …
Roche’s Tecentriq/Avastin combo smashes endpoints at Phase 3 in unresectable hepatocellular carcinoma
October 21, 2019Research and Development, Sales and Marketing Cancer, Roche, immunotherapy, pharma, tecentriq
New Phase 3 data has emerged demonstrating the efficacy of Roche’s Tecentriq (atezolizumab) in combination with Avastin (bevacizumab) in the …
Medical cannabis: Growth by leaps and bounds
October 18, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Canada, Canopy Growth, medical cannabis, pharma
This article follows parts one and two of our trio of in-depth pieces focusing on the growing medical cannabis phenomenon. …
2019 saw the FDA approve more generic drugs than ever before
October 18, 2019Medical Communications, Sales and Marketing FDA, US, generic drugs, pharma
Fiscal year 2019 was a record-breaking one, according to the FDA. The US regulator smashed its previous total for annual …
FDA greenlights Genentech’s Xofluza for acute, uncomplicated influenza
October 18, 2019Medical Communications FDA, Genetech, Roche, US, Xofluza, flu, pharma
Roche subsidiary Genentech has announced that its polymerase acidic endonuclease inhibitor Xofluza (baloxavir marboxil) has been awarded FDA approval in …
UCB’s bimekizumab meets primary and secondary endpoints, beating Janssen’s Stelara in chronic plaque psoriasis
October 17, 2019Research and Development Stelara, UCB Pharma, bimekizumab, pharma, plaque psoriasis
UCB Pharma has announced new data from the first of three Phase 3 studies investigating the efficacy of its IL-17A …
Latest content
Five Facts about cardiovascular disease
